Coffee halves risk of some breast cancer recurrence

Organisation: Position: Deadline Date: Location:

A new study led by researchers from Lund University in Sweden claims women diagnosed with breast cancer who are taking the drug tamoxifen could halve their risk of recurrence by drinking coffee. Medical News Today reports that the findings build on those from a previous study conducted by Lund University researchers in 2013, in which the team found a link between coffee consumption and reduced breast cancer recurrence in 300 women who used tamoxifen.

In that study, however, the researchers were unable to explain why coffee appeared to protect against the return of breast cancer in these women. "Now, unlike in the previous study, we have combined information about the patients' lifestyle and clinical data from 1,090 breast cancer patients with studies on breast cancer cells," say researchers Ann Rosendahl and Helena Jernström, both of Lund University and Skåne University Hospital, also in Sweden.

Hormone therapy is a standard treatment for patients with oestrogen receptor-positive (ER+) breast cancer, most commonly administered after a patient undergoes surgery for the disease. Tamoxifen is one drug used for hormone therapy. It works by preventing estrogen from binding to breast cancer cells, which stops them growing and dividing.

Of the 1,090 women with breast cancer included in the study, around 500 were treated with tamoxifen. The women's coffee consumption was assessed and allocated to one of three categories: low consumption (less than one cup a day), moderate consumption (two to four cups and day) and high consumption (five or more cups a day).

The researchers found that among the women who were treated with tamoxifen, those who had moderate or high coffee consumption had half the likelihood of breast cancer recurrence than those who had low coffee consumption or did not drink the beverage at all. What is more, the team found that tamoxifen-treated women who consumed at least two cups of coffee a day had smaller tumors and a lower proportion of hormone-dependent tumors than women who consumed less coffee.

Next, the researchers analysed the effects of two substances present in coffee – caffeine and caffeic acid – on breast cancer cells. The team found that both of these compounds – particularly caffeine – reduced cell division and increased cell death among both ER+ and oestrogen receptor-negative (ER-) breast cancer cells. When tamoxifen was applied, the effect was even stronger.

"This shows that these substances have an effect on the breast cancer cells and turn off signaling pathways that the cancer cells require to grow," say Rosendahl and Jernström. The team stresses, however, that breast cancer patients should not swap their medication for coffee. "But if you like coffee and are also taking tamoxifen," add Rosendahl and Jernström, "there is no reason to stop drinking it. Just two cups a day is sufficient to make a difference."

Full Medical News Today report Clinical Cancer Research abstract

Receive Medical Brief's free weekly e-newsletter

Related Posts

Thank you for subscribing to MedicalBrief

MedicalBrief is Africa’s premier medical news and research weekly newsletter. MedicalBrief is published every Thursday and delivered free of charge by email to over 33 000 health professionals.

Please consider completing the form below. The information you supply is optional and will only be used to compile a demographic profile of our subscribers. Your personal details will never be shared with a third party.

Thank you for taking the time to complete the form.